Cargando…
Modulation of the 5-Lipoxygenase Pathway by Chalcogen-Containing Inhibitors of Leukotriene A(4) Hydrolase
The 5-lipoxygenase (5-LOX) pathway gives rise to bioactive inflammatory lipid mediators, such as leukotrienes (LTs). 5-LOX carries out the oxygenation of arachidonic acid to the 5-hydroperoxy derivative and then to the leukotriene A(4) epoxide which is converted to a chemotactic leukotriene B(4) (LT...
Autores principales: | Teder, Tarvi, König, Stefanie, Singh, Rajkumar, Samuelsson, Bengt, Werz, Oliver, Garscha, Ulrike, Haeggström, Jesper Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145651/ https://www.ncbi.nlm.nih.gov/pubmed/37108702 http://dx.doi.org/10.3390/ijms24087539 |
Ejemplares similares
-
The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human Phagocytes
por: Tang, Xiao, et al.
Publicado: (2022) -
Functional Properties and Molecular Architecture of Leukotriene A4 Hydrolase, a Pivotal Catalyst of Chemotactic Leukotriene Formation
por: Haeggström, Jesper Z., et al.
Publicado: (2002) -
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase
por: Garscha, Ulrike, et al.
Publicado: (2017) -
Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening
por: Temml, Veronika, et al.
Publicado: (2017) -
A remarkable activity of human leukotriene A(4) hydrolase (LTA4H) toward unnatural amino acids
por: Byzia, Anna, et al.
Publicado: (2014)